Fortis Healthcare Limited — Q2 FY25
Fortis Healthcare delivered a strong Q2 FY25 with consolidated revenue of INR 1,988 crore (+12.3% YoY) and EBITDA of INR 435 crore (+31.9% YoY), driving a 330 bps margin expansi...
bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q1 FY25
Hospital EBITDA margin target of 20%+ for FY25
Management reiterated guidance for hospital business EBITDA margins to exceed 20% for the full year, despite Q1 margin of 18.5% impacted by one-offs and mix.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q1 FY25
Manesar 350-bed facility to be operational in Q2 FY25
The acquired Manesar facility is expected to start operations in the ongoing quarter, initially with 100 beds, ramping up to full capacity over 18 months.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1